A recent scientific study indicates that ovarian cancer may not be detectable in the blood using current technology until 10 years after the disease first starts to develop.
The researchers say their work could make future efforts to develop diagnostic blood tests more efficient.
Dr Laura McCallum, Cancer Research UK’s science communications officer, said:
“Detecting cancer at an early stage when treatment is more likely to be successful is one of the most promising ways to reduce deaths from the disease. Biomarkers have the potential to offer a simple, non-invasive way to detect cancer early and scientists, including our own, are working hard to find ones that can do this reliably.
“Mathematical models like this, designed to predict the most effective biomarkers, could help improve the bench to bedside success of such tests in the future.”
Cancerous cells do not die. On the contrary, healthy cells continue replacing the old and dead cells. This makes the cancerous cells multiply amassing to a tumor. It is for the above reasons that the ovarian cancer tumors are very vigorous in body destruction. They mature to hostility without notice and thus silently killing.
Though the cancer appears asymptomatic in early stages, it is detectable in late stages. Most people are diagnosed with ovarian cancer at the 3rd to 5th stage of the disease. This is when almost nothing or too little can be done to cure the patient.